register

News & Trends - MedTech & Diagnostics

Roche Diagnostics Australia to welcome new leadership in international promotion

Health Industry Hub | July 22, 2024 |

Diagnostics & MedTech News: Set to assume the role of Managing Director of Roche Diagnostics Australia in the coming months is the current Global Head of Solutions Marketing and Roche Academy, Anand Vairavan, who will be making an international transfer to take on this new leadership position.

Vairavan will succeed Allison Rossiter, who is set to become the CEO of the homegrown infectious disease company, Genetic Signatures, effective September 30. This transition concludes Rossiter’s notable 22-year tenure with Roche Diagnostics Australia.

Vairavan brings a wealth of experience to his new role, having held senior marketing and commercial positions at Roche, Novartis, and AutoGenomics. He has accumulated over eight years at Roche, showcasing exceptional leadership and strategic vision in senior marketing roles.

In related news, Roche Diagnostics has announced a new commercial partnership with Abacus dx. This collaboration will see Abacus dx handling the Australian distribution of Roche’s molecular diagnostics hardware and reagents.

Key products in this distribution agreement include the LightCycler 96 System, LightCycler 480 II System, MagNA Pure 24 System, and MagNA Pure 96 System. Additionally, Abacus dx will distribute Roche’s advanced tissue diagnostics solutions, such as the Ventana Discovery Ultra and a comprehensive suite of Sequencing Solutions reagents.

This commercial partnership unites Abacus dx’s extensive distribution network with Roche’s innovative solutions for the Australian healthcare sector.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Edwards Lifesciences VP challenges us to 'dream bigger' for underserved communities

Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities

Health Industry Hub | November 11, 2024 |

Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]

More


News & Trends - MedTech & Diagnostics

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Health Industry Hub | November 11, 2024 |

Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]

More


News & Trends - MedTech & Diagnostics

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Health Industry Hub | November 11, 2024 |

Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]

More


News & Trends - Pharmaceuticals

Australia’s first Cholesterol Awareness Week launched to tackle nation’s 'silent disease'

Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’

Health Industry Hub | November 11, 2024 |

Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]

More


This content is copyright protected. Please subscribe to gain access.